Skip to main content

Biogen

Biogen is a publicly listed biotechnology company headquartered in the United States. Founded in 1978, it researches, develops and markets treatments for serious neurological and neurodegenerative diseases including multiple sclerosis, spinal muscular atrophy and Alzheimer’s. The company has global operations in neuroscience-driven medicine, and is listed in the Forbes Global 2000.

North America
Pharmaceuticals & Biotechnology
Public
Not Engaged
Visit Website
ACT Core
G Uncommitted
Just Transition
6.7/100
Nature Benchmark
16.0/100
Social Benchmark
23.6/100
Gender Assessment
21.7/100
On this page

Subscribe to stay informed on our work

Keep up to date with all the latest from World Benchmarking Alliance

Join our newsletter